Cargando…
Tackling heterogeneity in treatment-resistant breast cancer using a broad-spectrum therapeutic approach
Tumor heterogeneity can contribute to the development of therapeutic resistance in cancer, including advanced breast cancers. The object of the Halifax project was to identify new treatments that would address mechanisms of therapeutic resistance through tumor heterogeneity by uncovering combination...
Autores principales: | Lowe, Leroy, LaValley, J. William, Felsher, Dean W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
OAE Publishing Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9771755/ https://www.ncbi.nlm.nih.gov/pubmed/36627896 http://dx.doi.org/10.20517/cdr.2022.40 |
Ejemplares similares
-
Utilizing Genomically Targeted Molecular Data to Improve Patient-Specific Outcomes in Autism Spectrum Disorder
por: Hausman-Cohen, Sharon, et al.
Publicado: (2022) -
Transformative tools for tackling tuberculosis
por: Gardiner, Jennifer L., et al.
Publicado: (2015) -
Should the Increased Awareness of the One Health Approach Brought by the COVID-19 Pandemic Be Used to Further Tackle the Challenge of Antimicrobial Resistance?
por: Rhouma, Mohamed, et al.
Publicado: (2021) -
Tilorone: a Broad-Spectrum Antiviral Invented in the USA and Commercialized in Russia and beyond
por: Ekins, Sean, et al.
Publicado: (2020) -
Tackling Mantle Cell Lymphoma in Europe
por: Horgan, Denis, et al.
Publicado: (2022)